Works matching DE "PEMETREXED"

Results: 774
    1
    2
    3
    4

    CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma.

    Published in:
    Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01552-5
    By:
    • Karnan, Sivasundaram;
    • Ota, Akinobu;
    • Murakami, Hideki;
    • Rahman, Md. Lutfur;
    • Wahiduzzaman, Md;
    • Hasan, Muhammad Nazmul;
    • Vu, Lam Quang;
    • Hanamura, Ichiro;
    • Inoko, Akihito;
    • Riku, Miho;
    • Ito, Hideaki;
    • Kaneko, Yoshifumi;
    • Hyodo, Toshinori;
    • Konishi, Hiroyuki;
    • Tsuzuki, Shinobu;
    • Hosokawa, Yoshitaka
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11

    Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial.

    Published in:
    Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 1089, doi. 10.20892/j.issn.2095-3941.2021.0026
    By:
    • Jingjing Wu;
    • Fenghua Gao;
    • Wenhua Wang;
    • Xudong Zhang;
    • Meng Dong;
    • Lei Zhang;
    • Xin Li;
    • Ling Li;
    • Zhenchang Sun;
    • Xinhua Wang;
    • Xiaorui Fu;
    • Linan Zhu;
    • Mengjie Ding;
    • Songtao Niu;
    • Zhaoming Li;
    • Yu Chang;
    • Feifei Nan;
    • Jiaqian Yan;
    • Hui Yu;
    • Xiaolong Wu
    Publication type:
    Article
    12

    <sup>99m</sup>Tc-macroaggregated albumin SPECT/CT predictive dosimetry and dose-response relationship in uveal melanoma liver metastases treated with first-line selective internal radiation therapy.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39994-7
    By:
    • Tabotta, Flavian;
    • Gnesin, Silvano;
    • Dunet, Vincent;
    • Ponti, Alexandre;
    • Digklia, Antonia;
    • Boughdad, Sarah;
    • Schaefer, Niklaus;
    • Prior, John O.;
    • Villard, Nicolas;
    • Tsoumakidou, Georgia;
    • Denys, Alban;
    • Duran, Rafael
    Publication type:
    Article
    13

    <sup>99m</sup>Tc-macroaggregated albumin SPECT/CT predictive dosimetry and dose-response relationship in uveal melanoma liver metastases treated with first-line selective internal radiation therapy.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39994-7
    By:
    • Tabotta, Flavian;
    • Gnesin, Silvano;
    • Dunet, Vincent;
    • Ponti, Alexandre;
    • Digklia, Antonia;
    • Boughdad, Sarah;
    • Schaefer, Niklaus;
    • Prior, John O.;
    • Villard, Nicolas;
    • Tsoumakidou, Georgia;
    • Denys, Alban;
    • Duran, Rafael
    Publication type:
    Article
    14

    Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37616-w
    By:
    • Watanabe, Sho;
    • Shimoi, Tatsunori;
    • Nishikawa, Tadaaki;
    • Kawachi, Asuka;
    • Okuma, Hitomi Sumiyoshi;
    • Tokura, Momoko;
    • Yazaki, Shu;
    • Mizoguchi, Chiharu;
    • Arakaki, Motoko;
    • Saito, Ayumi;
    • Kita, Shosuke;
    • Yamamoto, Kasumi;
    • Kojima, Yuki;
    • Sudo, Kazuki;
    • Noguchi, Emi;
    • Yoshida, Akihiko;
    • Kawai, Akira;
    • Fujiwara, Yasuhiro;
    • Yonemori, Kan
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial

    Published in:
    Cancer Research & Treatment, 2016, v. 48, n. 2, p. 458, doi. 10.4143/crt.2015.135
    By:
    • Jin Hyoung Kang;
    • Myung-Ju Ahn;
    • Dong-Wan Kim;
    • Eun Kyung Cho;
    • Joo-Hang Kim;
    • Sang Won Shin;
    • Xin Wang;
    • Jong Seok Kim;
    • Mauro Orlando;
    • Keunchil Park
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42900-4
    By:
    • Lim, Sun Min;
    • Peters, Solange;
    • Ortega Granados, Ana Laura;
    • Pinto, Gustavo dix Junqueira;
    • Fuentes, Christian Sebastián;
    • Lo Russo, Giuseppe;
    • Schenker, Michael;
    • Ahn, Jin Seok;
    • Reck, Martin;
    • Szijgyarto, Zsolt;
    • Huseinovic, Neda;
    • Zografos, Eleftherios;
    • Buss, Elena;
    • Stjepanovic, Neda;
    • O'Donnell, Sean;
    • de Marinis, Filippo
    Publication type:
    Article
    34

    Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42400-5
    By:
    • Pouyiourou, Maria;
    • Kraft, Bianca N.;
    • Wohlfromm, Timothy;
    • Stahl, Michael;
    • Kubuschok, Boris;
    • Löffler, Harald;
    • Hacker, Ulrich T.;
    • Hübner, Gerdt;
    • Weiss, Lena;
    • Bitzer, Michael;
    • Ernst, Thomas;
    • Schütt, Philipp;
    • Hielscher, Thomas;
    • Delorme, Stefan;
    • Kirchner, Martina;
    • Kazdal, Daniel;
    • Ball, Markus;
    • Kluck, Klaus;
    • Stenzinger, Albrecht;
    • Bochtler, Tilmann
    Publication type:
    Article
    35
    36
    37
    38

    MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma.

    Published in:
    Journal of Toxicology & Environmental Health: Part A, 2020, v. 83, n. 3, p. 126, doi. 10.1080/15287394.2020.1734891
    By:
    • Kim, Kihun;
    • Ko, Yeji;
    • Oh, Hyeoncheol;
    • Ha, Mihyang;
    • Kang, Junho;
    • Kwon, Eun Jung;
    • Kang, Ji Wan;
    • Kim, Youngjoo;
    • Heo, Hye Jin;
    • Kim, Guanghwi;
    • Kim, Jung Won;
    • Kim, Yun Hak
    Publication type:
    Article
    39

    Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers 2020, 12 , 666.

    Published in:
    2025
    By:
    • Cavazzoni, Andrea;
    • Digiacomo, Graziana;
    • Alfieri, Roberta;
    • La Monica, Silvia;
    • Fumarola, Claudia;
    • Galetti, Maricla;
    • Bonelli, Mara;
    • Cretella, Daniele;
    • Barili, Valeria;
    • Zecca, Alessandra;
    • Giovannetti, Elisa;
    • Fiorentino, Michelangelo;
    • Tiseo, Marcello;
    • Petronini, Pier Giorgio;
    • Ardizzoni, Andrea
    Publication type:
    Correction Notice
    40
    41
    42
    43
    44

    Targeted Therapy in Mesotheliomas: Uphill All the Way.

    Published in:
    Cancers, 2024, v. 16, n. 11, p. 1971, doi. 10.3390/cancers16111971
    By:
    • Bertoli, Elisa;
    • De Carlo, Elisa;
    • Bortolot, Martina;
    • Stanzione, Brigida;
    • Del Conte, Alessandro;
    • Spina, Michele;
    • Bearz, Alessandra
    Publication type:
    Article
    45
    46
    47

    Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma.

    Published in:
    Cancers, 2023, v. 15, n. 3, p. 662, doi. 10.3390/cancers15030662
    By:
    • Kusamura, Shigeki;
    • Baratti, Dario;
    • De Simone, Michele;
    • Pasqual, Enrico Maria;
    • Ansaloni, Luca;
    • Marrelli, Daniele;
    • Robella, Manuela;
    • Accarpio, Fabio;
    • Valle, Mario;
    • Scaringi, Stefano;
    • Biacchi, Daniele;
    • Palopoli, Carmen;
    • Gazzanelli, Sergio;
    • Guaglio, Marcello;
    • Deraco, Marcello
    Publication type:
    Article
    48
    49
    50